Myocardial-damage markers |
Myoglubin and Tropinon I |
Buffer |
Direct immunoassay |
3 ng/mL |
Two-channel multi-mode SPR |
[176] |
Tropinin T |
|
Direct immunoassay |
0.01 ng/mL |
SPR |
[177] |
Human Tropinone I |
|
Direct assay |
2.5–40 ng/mL |
Wavelength modulation SPR |
[178] |
Sandwich immunoassay |
0.5-20 ng/mL |
Fatty acid binding protein (H-FABP) |
Buffer |
Competitive immunoassay |
200 ng/mL |
Planar SPR and fiber optic-SPR |
[179] |
Cancer markers |
Prostate-Specific Antigen (PSA) |
Buffer |
Direct assay |
0.15 ng/mL |
IBIS II dual channel SPR |
[180] |
Sandwich immunoassays |
2.4 ng/mL |
Serum |
Direct enhancement |
10 ng/mL |
Biacore 2000 |
[181] |
Interleukin-8 (IL-8) |
Buffer |
Sandwich immunoassay |
2.5 pM |
Biacore |
[182] |
Saliva |
184 pM |
Hormones |
Estrone and estradiol |
Buffer |
Inhibition immunoassay |
0.01–3000 ng/mL |
Biacore |
[183] |
17-β-Estradiol |
Buffer |
Inhibition immunoassay |
0.47–21.4 nM |
|
[184] |
Progesterone |
Buffer |
Indirect inhibition immunoassay |
143 pg/mL |
Biacore |
[185] |
Insulin growth factor-1 |
Milk |
Direct immunoassay |
0.5–1 ng/mL |
Biacore |
[186] |
Human chronic gonadotropin (hCG) |
Buffer |
|
0.05–1 µg/mL |
|
[187] |
Drugs |
Morphine |
Buffer |
Inhibition immunoassay |
0.1–10 ng/mL |
SPR and QCM |
[188] |
Morphine-3 glucronide (M3G) |
Buffer |
Indirect inhibition immunoassay |
0.7 ng/mL |
Biacore 1000 |
[189] |
Dilute urine |
2.4 ng/mL |
Anti-thrombotic agent Fragmin |
Buffer |
Inhibition immunoassay |
625 ng/mL |
Biacore 3000 |
[190] |
7-Hydroxycoumarin |
Diluted serum |
Competitive and Inhibition immunoassays |
0.5–80 µg/mL |
Biacore |
[191] |
Oral anticoagulant 4'-aminowarafrin |
Plasma samples |
Inhibition immunoassay |
4–250 ng/mL |
Biacore 3000 |
[192] |
β-Lactam antibiotics |
Milk |
Direct inhibition |
4 µg/kg |
Biacore 3000 |
[193] |
β-Lactam antibiotics (penicillin G) |
Milk |
Inhibition immunoassay |
1.2 µg/kg |
Biacore Q |
[194] |